Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Sepsis: pathophysiology and clinical management
It may take a few minutes for the powder to dissolve completely
The gut microbiome comes into play here in making sure that the metabolites are excreted and not reabsorbed
IV glutathione has FDA approval as an adjunct for cisplatin chemotherapy protection in cancer treatment
Conclusion: S100B and S100B-creatinine ratio did not show significantly higher values after ischemic strokes and was not feasible to differ ischemic stroke patients from healthy controls Disclosure of interest: KK: nothing to disclose, CF: nothing to disclose, FB: nothing to disclose, GH: nothing to disclose E-Posters - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.01 - PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE P2575 - ESOC25-571 ASTROCYTE NEUREXIN1 IS A POTENTIAL TARGET FOR NEUROPROTECTION IN ACUTE ISCHEMIC STROKE Baoshan Qiu 1 , Yilong Wang 1 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China Background and Aims: Persistent brain injury following acute ischemic stroke significantly affects prognosis, but its mechanisms remain poorly understood
